Affiliation: University of Hull
- The biological variation of insulin resistance in polycystic ovarian syndromeV Jayagopal
Department of Medicine, University of Hull, United Kingdom
J Clin Endocrinol Metab 87:1560-2. 2002..IR, measured using the homeostasis model assessment model, is significantly greater and more variable for overweight patients with PCOS. Therefore, this inherent variability needs to be accounted for in studies of IR in PCOS...
- Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetesVijay Jayagopal
Department of Medicine, University of Hull, Hull, U K
Diabetes Care 25:1709-14. 2002..The aim of this study was to determine whether a dietary supplement with soy protein and isoflavones affected insulin resistance, glycemic control, and cardiovascular risk markers in postmenopausal women with type 2 diabetes...
- The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistanceV Jayagopal
Department of Medicine, University of Hull, United Kingdom HU3 2RW
J Clin Endocrinol Metab 88:1528-33. 2003..However, SHBG and testosterone concentrations measured in isolation are inherently unsuitable for use as tests to detect hyperandrogenemia...
- Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndromeV Jayagopal
Department of Medicine, University of Hull, Michael White Centre for Diabetes and Endocrinology, Hull Royal Infirmary, Hull HU3 2RW, UK
J Clin Endocrinol Metab 90:729-33. 2005..The reduction in total testosterone was similar to that seen after treatment with metformin. Therefore, orlistat may prove to be a useful adjunct in the treatment of PCOS...
- Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controlsL W Cho
Department of Endocrinology and Diabetes, University of Hull, Hull, UK
Horm Metab Res 43:141-5. 2011..Since anovulatory PCOS therefore mimics the IR features of type 2 diabetes more closely, anovulation may be particularly associated with a higher cardiovascular risk compared to PCOS patients who ovulate...
- The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetesLi Wei Cho
Department of Medicine University of Hull, Hull Royal Infirmary, Hull, UK
Ann Clin Biochem 46:218-21. 2009..To test this hypothesis we compared the mean and biological variation in IR in PCOS to that of T2DM and to age- and weight-matched controls...
- Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemiaL W Cho
Department of Medicine, University of Hull, UK
Clin Endocrinol (Oxf) 68:390-4. 2008..The aim of this study was to compare the biological variability of total testosterone with that of the biological variability of both the FAI and BioT, to determine the least variable measurement for clinical practice...
- Erythropoetin treatment significantly alters measured glycated haemoglobin (HbA1c)J M Ng
Diabet Med 25:239-40. 2008